Skip To Main Content
N. He on Muck Rack

N. He

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to N. He’s profile

Articles by N. He

Identification and fine mapping of a new bacterial blight resistance gene, Xa43(t), in Zhangpu wild rice (Oryza rufipogon)

|
By F. Huang, Fujian Academy, N. He, M. Yu
| Wiley Online Library Verified
The datasets used and analysed during the current study are available from the corresponding author upon reasonable request. The genome sequences of LOC_Os11g36920, LOC_Os11g36930, LOC_Os11g36940 and LOC_Os11g36950 can be found in the NCBI database (http://www.ncbi.nlm.nih.gov/), and the GenBank accession numbers are ABA94482.1, ABA94483.1, ABA94484.1, ABA94485.1, respectively. All data generated or analysed during this study are included in this published article.
Open in Who Shared Issue with article?

Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use

|
By K.N. Hayes, N. He, K.A. Brown, A.M. Cheung
| link.springer.com
Abstract Summary Most adherence studies only consider treatment following a first prescription. Using an extended follow-up, we found that 60% of seniors starting oral bisphosphonate therapy were exposed for ≥ 3 years (48% for ≥ 5 years). Studies are needed to examine the benefits and harms of continuing bisphosphonate therapy beyond 3 years.
Open in Who Shared Issue with article?

The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials

|
By S. Su, N. He
| link.springer.com
Original Article First Online: 07 February 2019 Abstract Summary In our systematic review and meta-analysis, we comprehensively evaluated menatetrenone in the management of osteoporosis. We found that menatetrenone decreased the ratio of undercarboxylated osteocalcin to osteocalcin (ucOC/OC) and improved lumbar BMD compared with placebo based on the 18 studies assessed. However, its benefit in fracture risk control was uncertain.
Open in Who Shared Issue with article?
Show More